RxDoctor Payments DataLook up a doctor →

Matthew Berke, MD

Physical Medicine & Rehabilitation · Birmingham, ALNPI 1841268885

Payments from drug & device makers

$6,163in general payments, 2019–2025

Across 429 payments — averaging $14.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Forte Bio-pharma LLC$570
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$496
  • Scilex Pharmaceuticals Inc.$345
  • Collegium Pharmaceutical, Inc.$242
  • Biodelivery Sciences International, Inc.$230
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$6,142100%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,163 in reported general payments places this provider in the 85th percentile of 104 physical medicine & rehabilitation providers in Alabama.

See all physical medicine & rehabilitation providers in Alabama

Medicare billing

Part B allowed, 2024
$94,106
Medicare patients
261
Services billed
2,391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen3,439$122,910
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen4,370$107,846
PercocetOxycodone Hcl/Acetaminophen20$59,286
ProlateOxycodone Hcl/Acetaminophen21$41,317
Gabapentin2,276$33,986
Buprenorphine136$33,514
Xtampza ErOxycodone Myristate29$20,792
Pregabalin773$18,186
Lidocaine136$16,476
Diclofenac Sodium318$13,811
Tizanidine Hcl1,023$11,347
LinzessLinaclotide13$11,240
OxycontinOxycodone Hcl25$11,141
MovantikNaloxegol Oxalate13$5,276
Baclofen351$4,160

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Forte Bio-pharma LLCProlate$570$41,31721 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine Hcl$47$37,860337 claims
Collegium Pharmaceutical, Inc.Xtampza Er$242$20,79229 claims
AbbVieLinzess$169$11,24013 claims
Redhill Biopharma Inc.Movantik$59$5,27613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 104 physical medicine & rehabilitation providers in Alabama.

Other physical medicine & rehabilitation in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →